GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » Operating Margin %

Curative Biosciences (Curative Biosciences) Operating Margin % : 0.00% (As of Mar. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Curative Biosciences's Operating Income for the three months ended in Mar. 2018 was $-0.03 Mil. Curative Biosciences's Revenue for the three months ended in Mar. 2018 was $0.00 Mil. Therefore, Curative Biosciences's Operating Margin % for the quarter that ended in Mar. 2018 was 0.00%.

The historical rank and industry rank for Curative Biosciences's Operating Margin % or its related term are showing as below:


CBDX's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.43
* Ranked among companies with meaningful Operating Margin % only.

Curative Biosciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Curative Biosciences's Operating Income for the three months ended in Mar. 2018 was $-0.03 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2018 was $-0.52 Mil.


Curative Biosciences Operating Margin % Historical Data

The historical data trend for Curative Biosciences's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences Operating Margin % Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -517.28 - - - -

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Curative Biosciences's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curative Biosciences's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Operating Margin % falls into.



Curative Biosciences Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Curative Biosciences's Operating Margin % for the fiscal year that ended in Jun. 2017 is calculated as

Operating Margin %=Operating Income (A: Jun. 2017 ) / Revenue (A: Jun. 2017 )
=-0.053 / 0
= %

Curative Biosciences's Operating Margin % for the quarter that ended in Mar. 2018 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2018 ) / Revenue (Q: Mar. 2018 )
=-0.032 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biosciences  (OTCPK:CBDX) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Curative Biosciences Operating Margin % Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines